These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 25917675)
1. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria. Mo AX; Pesce J; Hall BF Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675 [TBL] [Abstract][Full Text] [Related]
2. The Development of Whole Sporozoite Vaccines for Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK Front Immunol; 2018; 9():2748. PubMed ID: 30619241 [TBL] [Abstract][Full Text] [Related]
3. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies. Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525 [TBL] [Abstract][Full Text] [Related]
11. Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials. Abuelazm MT; Elzeftawy MA; Kamal MA; Badr H; Gamal M; Aboulgheit M; Abdelazeem B; Abd-Elsalam S; Abouzid M Infection; 2024 Jun; 52(3):707-722. PubMed ID: 38319556 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112 [TBL] [Abstract][Full Text] [Related]
13. Live attenuated pre-erythrocytic malaria vaccines. Keitany GJ; Vignali M; Wang R Hum Vaccin Immunother; 2014; 10(10):2903-9. PubMed ID: 25483648 [TBL] [Abstract][Full Text] [Related]
14. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719 [TBL] [Abstract][Full Text] [Related]
15. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens. Bettencourt P Front Immunol; 2020; 11():190. PubMed ID: 32153565 [No Abstract] [Full Text] [Related]
16. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Mordmüller B; Surat G; Lagler H; Chakravarty S; Ishizuka AS; Lalremruata A; Gmeiner M; Campo JJ; Esen M; Ruben AJ; Held J; Calle CL; Mengue JB; Gebru T; Ibáñez J; Sulyok M; James ER; Billingsley PF; Natasha KC; Manoj A; Murshedkar T; Gunasekera A; Eappen AG; Li T; Stafford RE; Li M; Felgner PL; Seder RA; Richie TL; Sim BK; Hoffman SL; Kremsner PG Nature; 2017 Feb; 542(7642):445-449. PubMed ID: 28199305 [TBL] [Abstract][Full Text] [Related]
17. Quantification of Plasmodium knowlesi versus Plasmodium falciparum in the rhesus liver: implications for malaria vaccine studies in rhesus models. Shears MJ; Seilie AM; Kim Lee Sim B; Hoffman SL; Murphy SC Malar J; 2020 Aug; 19(1):313. PubMed ID: 32867784 [TBL] [Abstract][Full Text] [Related]
18. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Seder RA; Chang LJ; Enama ME; Zephir KL; Sarwar UN; Gordon IJ; Holman LA; James ER; Billingsley PF; Gunasekera A; Richman A; Chakravarty S; Manoj A; Velmurugan S; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Plummer SH; Hendel CS; Novik L; Costner PJ; Mendoza FH; Saunders JG; Nason MC; Richardson JH; Murphy J; Davidson SA; Richie TL; Sedegah M; Sutamihardja A; Fahle GA; Lyke KE; Laurens MB; Roederer M; Tewari K; Epstein JE; Sim BK; Ledgerwood JE; Graham BS; Hoffman SL; Science; 2013 Sep; 341(6152):1359-65. PubMed ID: 23929949 [TBL] [Abstract][Full Text] [Related]
19. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hoffman SL; Billingsley PF; James E; Richman A; Loyevsky M; Li T; Chakravarty S; Gunasekera A; Chattopadhyay R; Li M; Stafford R; Ahumada A; Epstein JE; Sedegah M; Reyes S; Richie TL; Lyke KE; Edelman R; Laurens MB; Plowe CV; Sim BK Hum Vaccin; 2010 Jan; 6(1):97-106. PubMed ID: 19946222 [TBL] [Abstract][Full Text] [Related]
20. Novel ELISA method as exploratory tool to assess immunity induced by radiated attenuated sporozoites to decipher protective immunity. Knepper TA; Duncan EH; Savransky T; Bergmann-Leitner ES Malar J; 2017 Nov; 16(1):484. PubMed ID: 29187199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]